Zastosowanie w medycynie pochodnych indolu i jego kompleksów z biometalami

• Autorzy: Turek M. , Łodyga-Chruścińska E.

Warianty tytułu

EN

Application in medicine of indol the derivatives and its complexes with biometals

• Języki publikacji: PL

Abstrakty

PL

W oparciu o dane literaturowe przedstawiono charakterystykę i właściwości związków zawierających pierścień indolu. Pochodne związki indolu występują szeroko w przyrodzie w tkankach wielu roślin i zwierząt. Wykazują właściwości, które pozwalają na wykorzystanie ich w przemyśle farmaceutycznym. Dodatkowo mają zdolność kompleksowania biometali, dzięki czemu zyskują nowe właściwości lecznicze. W pracy dokonano przeglądu analogów oraz związków kompleksowych indoli, które już mają lub będą miały w przyszłości zastosowanie w medycynie i farmacji.

EN

Properties and applications of compounds containing indol rings have been reported. The indol derivatives have a broad occurrence in nature, in tissues of many plants and animals. Their properties make them applicable in pharmaceutical industry. Additionally they have a complexing ability towards biometals, therefore their new potential medicinal capabilities are still under investigation. Our paper is a literature review of indol derivatives and complexes which already have or may have in the future an usage in medicine and pharmacy.

Słowa kluczowe

PL

pierścień indolu; pochodne związki indolu; przemysł farmaceutyczny; kompleksowanie biometali; właściwości lecznicze

EN

indol ring; indol derivatives; pharmaceutical industry; biometals complexing; medicinal capabilities

• Wydawca: Wydawnictwo Politechniki Łódzkiej
• Czasopismo: Zeszyty Naukowe. Chemia Spożywcza i Biotechnologia / Politechnika Łódzka
• Rocznik: 2008
• Tom: Z. 72
• Strony: 73--88
• Opis fizyczny: Bibliogr. 47 poz.

Twórcy

autor

Turek M.

autor

Łodyga-Chruścińska E.

• Instytut Podstaw Chemii Żywności, Politechnika Łódzka

Bibliografia

• [1] Crouch I.J, Smith M.T., Vanstaden J., Lewis M.J., Hoad G.V.: Identification of auxins in a commercial seaweed concentrate, J. Plant Physiol., 139, 590-594, (1992).
• [2] Moran P.M., Moser P.C.: MDL 73, 147EF a 5-HT3 antagonist facilitates latent inhibition in the rat, Pharmacol. Biochem. Behav., 42, 519, (1992).
• [3] Chauhan S.M.S., Mohapatra P.P., Kalra B., Kohli T.S., Satapathy S.: Biomimetic oxidation of indole-3-acetic acid and related substrates with hydrogen peroxide catalysed by 5,10,15,20-tetrakis 2prime; 6prime;-dichloro-3prime;-sulfonatophenyl) porphyrinatoiron(IIl) hydrate in aqueous solution and AOT reverse micelles, J. Mol. Catal. A: Chem., 113, 239, (1996).
• [4] Morzyk-Ociepa B., Michalska D., Pietraszko A.: Structures and vibrational spectra of indole carboxylic acids. Part I. Indole-2-carboxylic acid, J. Mol. Struct., 688, 87, (2004).
• [5] Morzyk-Ociepa B., Michalska D., Pietraszko A.: Structures and vibrational spectra of indole carboxylic acids. Part II. 5-Methoxyindole-2-carboxylic acid, J. Mol. Struct., 688, 79, (2004).
• [6] Pradhan C., Pattnaik S., Dwari M., Patnaik S.N., Chand P.K.: Efficient plant regeneration from cell suspension-derived callus of East Indian rosewood (Dalbergia latifolia Roxb.), Plant Cell Rep., 18, 138, (1998).
• [7] Okabe N., Adachi Y.: 1H-Indole-3-propionic Acid, Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 54, 386, (1998).
• [8] Pattnaik S.K., SahooY., Chand P.K.: Micropropagation of a fruit tree, Morus australis Poir. syn. M. acidosa Griff, Plant Cell Rep., 15, 841, (1996).
• [9] Pradhan C., Kar S., Patnaik S.N., Chand P.K.: Propagation of Dalbergia sissoo Roxb. through in vitro shoot proliferation from cotyledonary nodes, Plant Cell Rep., 18, 122, (1998).
• [10] Young-Kwan L., Cheon-Cyu C.: Expedient synthesis of indoles from N-boc antyhydrozines, Tetrahedron Lett., 45, 1857-1849, (2004).
• [11] Kydyakova T.I., Sarycheva N.Yu., Kamensky A.A.: Study of the behavior of white rats with destroyed olfactory epithelium, Human and Animal Physiology Department, Faculty of Biology, 45, 254, (1995).
• [12] Takani M., Masuda H, Yamauchi O.: Palladium(II) complex formation by indole-3-acetate. Mixed ligand complexes involving a unique spiro-ring formed by cyclopalladation, Inorg. Chim. Acta, 235, 367, (1995).
• [13] Cheetham R.D., Mikloiche C., Glubiak M., Weathers P.: Micropropagation of a recalcitrant male asparagus clone (MD 22-8), Plant Cell Tissue and Organ Culture, 31, 15, (1992).
• [14] Blume H.H., Schug B.S.: The biopharmacetics classification system (BCS): Class III drugs - better candidates for BA/BE waiver?, Eur. J. Pharm. Sci., 9, 117-121, (1999).
• [15] Morgan Y.R., Turner P., Kennedy B.J., Hambley T.W.: Preparation and characterization of dinuclear copper-indomethacin anti-inflammatory drugs, Inorg. Chim. Acta, 324, 150, (2001).
• [16] Dejaco Ch., Duftner Ch., Schirmer M.: Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases, Rheumatol Int. 27, 351-355, (2007).
• [17] Lione A.; Scialli A.R.: The developmental toxicity of indomethacin and sulindac, Reprod. Toxicol., 9, 7-20, (1995).
• [18] Bellamy N.: Etodolac in the management of pain: A clinical review of a multipurpose analgesic, Inflammopharmacology, 5, 139-152, (1997).
• [19] Arnao M.B., Sanchezbravo J., Acosta M.: Indole-3-carbinol as a scavenger of free radicals, Biochem. Mol. Biol. Int., 39, 1125, (1996).
• [20] Podsędek A.: Natural antioxidants and antioxidant capacity of Brassica vegetables, LWT- Food Sci. Technol. 40, 1-11, (2007).
• [21] Dashwood R.H.: Indole-3-carbinol: anticarcinogen or tumor promoter in brassica vegetables?, Chem. Biol. Interact., 110, 1-5, (1998).
• [22] Michnovicz J.J.: Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol, Nutr. Cancer, 16, 59-66, (1991).
• [23] Michnovicz J.J.: Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans, Natl. Cancer Inst. 89, 718-724, (1997).
• [24] Waikar M.V., Hegde S.S., Ford A.P.D. W., Clarke D.E.: Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1H- benzimidazole- 1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine, J. Pharmacol. Exp. Ther., 264, 654, (1993).
• [25] Lawton C.L., Blundell J.E.: 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of D-fenfluramine and DOI, Pharmacol. Biochem. Behav., 46, 349, (1993).
• [26] Langle U.W., Wolf A., Cordier A.: Enhancement of SDZ ICT 322-induced cataracts and skin changes in rats following vitamin E- and selenium-deficient diet, Arch. Toxicol., 71, 283, (1997).
• [27] Kandasamy S.B.: Effect of Ondansetron and ICS 205-930 on Radiation-Induced Hypothermia in Rats, Radiat. Res., 147, 741, (1997).
• [28] Gupta S.S., Sharma S., Narula A.K.: Heterocarboxylates of an unsymmetrical diorganotin(IV)dichlorate, J. Chem. Res., 11, 406, (1994).
• [29] Morzyk-Ociepa B., Rozycka-Sokolowska E.: Structures and spectroscopic studies of indolecarboxylic acids. Part III. Diamminetetrakis-μ-(O,O'-indole-3-carboxylate) dicopper(II), J. Mol. Struc, 784, 69-77, (2006).
• [30] Romanelli M.N., Ghelardini C., Dei S., Matucci R., Mori F., Scapecchi S., Teodori E., Bartolini A., Galli A., Giotti A., Gualtieri F.: Synthesis and biological activity of a series of aryl tropanyl esters and amides chemically related to 1H-indole-3-carboxylic acid endo 8-methyl-8-azabicyclo[3.2.1.]oct-3-yl ester: development of a 5-HT4 agonist endowed with potent antinociceptive activity, Arzneim.-Forsch., 42, 913, (1993).
• [31] Karle I.L., Britts K., Gum P.: Crystal and molecular structure of 3-indolylacetic acid, Acta Cryst. 17, 496, (1964).
• [32] Endo S., Itoh M, Serizawa O., Serotonergic regulation of the spinal cord content of thyrotropin releasing hormone in the cerebellar ataxia mutant mouse, J. Neurol. Sci., 118, 194, (1993).
• [33] Jiang J.C., Gietzen D. W.: Anorectic response to amino acid imbalance: a selective serotonin 3 effect?, Pharmacol. Biochem. Behav., 47, 59, (1994).
• [34] Contesse V., Hamel C., Delarue C., Lefebvre H., Vaudry H.: Effect of a series of 5-HT4 receptor agonists and antagonists steroid secretion by the adrenal gland in vitro, Eur. J. Pharmacol., 265, 27, (1994).
• [35] Huang Y.L., Chen C.C., Hsu F.L., Chen C.F.: A new lignan from Phyllanthus virgatus, J. Nat. Prod., 59, 520, (1996).
• [36] Morzyk-Ociepa B., Rozycka-Sokolowska E.: X-ray and infrared spectrum on metal complexes with indolecarboxylic acids. Part V. Catena-poly[{aqua(h2-indole-3-propionato-O,O0)zinc}-h2-:-m-indole-3-propionato-O,O0:-O], Vib. Spectrosc, 43, 405-414, (2007).
• [37] Pattnaik S.K. Chand P.K.: Rapid clonal propagation of three mulberries, Morus cathayana Hemsl., M. Ihou Koiz. and M. serrata Roxb., through in vitro culture of apical shoot buds and nodal explants from mature trees, Plant Cell Rep., 16, 503, (1997).
• [38] Gartz J.: Variation der Indolalkaloide von Psilocybe cubensis durch unterschiedliche Kultivierungsbedingungen, Beiträge z. Kenntnis d. Pilze Mitteleuropas, 3, 275, (1987).
• [39] Hart H., Craine L.E., Hart D.J.: Chemia organiczna, PZWL, Warszawa (1999) 329.
• [40] Appel J.B., West W.B., Buggy J.: LSD, 5-HT (serotonin), and the evolution of a behavioral assay, Neurosci. Biobehav. Rev., 27, 693-701, (2004).
• [41] Kaneez F.S., Arshad S.S.: The metabolism of serotonin in neuronal cells in culture and platelets, Exp. Brain Res., 183, 411-416, (2007).
• [42] Stocking J., Zenk H.: Isovincoside (strictosidine), the key intermediate in the enzymatic formation of indole alkaliods, Febs Lett., 79, 233-237, (1977).
• [43] Rinaldi A.C.: Meeting report - Copper research at the top, BioMetals, 13, 9-13, (2000).
• [44] Takeda A.: Zinc homeostasis and functions of zinc in the brain, BioMetals, 14, 343-351, (2001).
• [45] Zhou Q., Hambley T.W., Kennedy B.J., Lay P.A., Turner P., Warwick B., Biffin J.R., Regtop H.L.: Syntheses and Characterization of Anti-inflammatory Dinuclear and Mononuclear Zinc Indomethacin Complexes. Crystal Structures of [Zn2(Indomethacin)4(L)2] (L = N,N-Dimethylacetamide, Pyridine, 1-Methyl-2-pyrrolidinone) and [Zn(Indomethacin)2 (L1)2] (L1 = Ethanol, Methanol), Inorg. Chem. 39, 3742, (1999).
• [46] Weder J.E., Dillon C.T., Hambley T.W., Kennedy B.J., Lay P.A., Biffin J.R., Regtop H.L., Davies N.M.: Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized, Coord. Chem. Rev., 232, 95-126, (2002).
• [47] Morzyk-Ociepa B., Marciniak B.: X-ray and vibrational spectra on metal complexes with indolecarboxylic acids: Part IV. Catena-poly[{aqua(η2-indole-3-carboxylato-O,O')zinc}-μ-indole-3-carboxylato-O:O'], Vib. Spectrosc, 43, 297-305, (2007).